help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, B.
Right arrow Articles by McCray, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, B.
Right arrow Articles by McCray, P. B., Jr

Am. J. Respir. Crit. Care Med., Vol 151, No. 3, 03 1995, 899-903.

Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis

B Stewart, J Zabner, AP Shuber, MJ Welsh and PB McCray Jr
Department of Pediatrics, Howard Hughes Medical Institute, University of Iowa, College of Medicine, Iowa City 52242.

Since its introduction in 1959, the sweat test has remained the "gold standard" diagnostic test for cystic fibrosis (CF). It is apparent that CF encompasses a wide spectrum of disease, from meconium ileus and severe respiratory compromise in infants to the presentation of mild pulmonary symptoms and no evidence of gastrointestinal disease in adults. In patients with lung disease that might otherwise be consistent with CF, normal sweat chloride (Cl-) values have tended to exclude the diagnosis. In this report we describe two patients from two families with the compound heterozygotic CF mutations delta F508/3849 + 10 kb C-->T. These patients had mild manifestations of disease, including clinical pancreatic sufficiency (normal growth without pancreatic enzyme supplementation) and absence of azoospermia. Sweat Cl- values were in the normal range. However, both patients developed bronchiectasis, progressive obstructive lung disease, and colonization with Pseudomonas. The diagnosis of CF was made using nasal transepithelial voltage measurements and genotyping. These cases emphasize the need to maintain a high index of suspicion of CF in atypical cases, and to pursue alternative diagnostic tests to confirm a diagnosis of CF suspected on clinical grounds, despite normal sweat test results.


This article has been cited by other articles:


Home page
 ChestHome page
Y. Yaakov, E. Kerem, Y. Yahav, J. Rivlin, H. Blau, L. Bentur, M. Aviram, E. Picard, T. Bdolah-Abram, and M. Wilschanski
Reproducibility of Nasal Potential Difference Measurements in Cystic Fibrosis
Chest, October 1, 2007; 132(4): 1219 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
I. Batal, M.-B. Ericsoussi, J. E. Cluette-Brown, B. P. O'Sullivan, S. D. Freedman, J. E. Savaille, and M. Laposata
Potential Utility of Plasma Fatty Acid Analysis in the Diagnosis of Cystic Fibrosis
Clin. Chem., January 1, 2007; 53(1): 78 - 84.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Gilljam, L. Ellis, M. Corey, J. Zielenski, P. Durie, and D. E. Tullis
Clinical Manifestations of Cystic Fibrosis Among Patients With Diagnosis in Adulthood
Chest, October 1, 2004; 126(4): 1215 - 1224.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. LEBECQUE, T. LEAL, C. DE BOECK, M. JASPERS, H. CUPPENS, and J.-J. CASSIMAN
Mutations of the Cystic Fibrosis Gene and Intermediate Sweat Chloride Levels in Children
Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 757 - 761.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Wilschanski, H. Famini, N. Strauss-Liviatan, J. Rivlin, H. Blau, H. Bibi, L. Bentur, Y. Yahav, H. Springer, M.R. Kramer, et al.
Nasal potential difference measurements in patients with atypical cystic fibrosis
Eur. Respir. J., June 1, 2001; 17(6): 1208 - 1215.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. Marchand, C. Verellen-Dumoulin, M. Mairesse, L. Delaunois, P. Brancaleone, J.-F. Rahier, and O. Vandenplas
Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations and 5T Allele in Patients With Allergic Bronchopulmonary Aspergillosis
Chest, March 1, 2001; 119(3): 762 - 767.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. Desmarquest, D. Feldmann, A. Tamalat, M. Boule, B. Fauroux, G. Tournier, and A. Clement
Genotype Analysis and Phenotypic Manifestations of Children With Intermediate Sweat Chloride Test Results
Chest, December 1, 2000; 118(6): 1591 - 1597.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
P. M. QUINTON
Physiological Basis of Cystic Fibrosis: A Historical Perspective
Physiol Rev, January 1, 1999; 79(1): 3 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
U. PRADAL, C. CASTELLANI, A. DELMARCO, and G. MASTELLA
Nasal Potential Difference in Congenital Bilateral Absence of the Vas Deferens
Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 896 - 901.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
C. WALLIS
Diagnosing cystic fibrosis: blood, sweat, and tears
Arch. Dis. Child., February 1, 1997; 76(2): 85 - 88.
[Full Text]

Home page
 NEJMHome page
L. S. Rusakow, M. Guarcn, H. J. Veeze, K.-H. Gan, and H. G.M. Heijerman
A Cystic Fibrosis Mutation Associated with Mild Lung Disease
N. Engl. J. Med., December 14, 1995; 333(24): 1644 - 1644.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society